In addition to these classic biomarkers, the newest ones have shown promising results for the diagnosis of early-stage kidney injury: cystatin C, KIM-1, NAG, NGAL, β2-microglobulin, osteopontin, TIMP-1, GST-α, without being implemented in clinical practice [35]. This evidence concerns the gene CST3 and injury.